Skip to main content
. 2020 Sep 2;10:1518. doi: 10.3389/fonc.2020.01518

Table 3.

Univariable and multivariable cox regression analysis of the sequence of chemotherapy and immunotherapy.

Univariate analysis Multivariable analysis
HR (95% CI) P HR (95% CI) P
A: Chemotherapy plus immunotherapy regardless of RT (n = 705)
CTx plus immunotherapy CTx and Immx within 30 days Ref Ref
Immx 31–90 days before CTx 1.179 (0.815–1.705) 0.384 1.057 (0.716–1.561) 0.781
Immx 91–180 days before CTx 0.901 (0.611–1.329) 0.598 0.900 (0.584–1.388) 0.635
B: Only chemotherapy plus immunotherapy sample (n = 479)
CTx plus immunotherapy CTx and immx within 30 days Ref Ref
Immx 31–90 days before CTx 1.166 (0.762–1.784) 0.478 1.151 (0.731–1.812) 0.544
Immx 91–180 days before CTX 0.984 (0.638–1.516) 0.941 0.952 (0.595–1.523) 0.838
C: Chemoradiation plus immunotherapy sample (n = 226)
CTx plus immunotherapy CTx and immx within 30 days Ref Ref
Immx 31–90 days before CTx 0.969 (0.455–2.065) 0.936 0.860 (0.360–2.053) 0.734
Immx 91–180 days before CTX 0.561 (0.228–1.377) 0.207 0.549 (0.165–1.826) 0.328

CTx, chemotherapy; Immx, immunotherapy; RTx, radiation therapy; Ref, reference.